Glucocorticoid-induced osteoporosis: when and who should we treat?

被引:2
|
作者
Morel, Gauthier [1 ]
Biver, Emmanuel [2 ]
Borg, Severine [3 ]
Chopin, Florence [4 ]
Hoppe, Emmanuel [5 ]
Rajzbaum, Gerald [6 ]
机构
[1] Ctr Hosp, Serv Rhumatol, F-59322 Valenciennes, France
[2] Hop Roger Salengro, Dept Univ Rhumatol, F-59037 Lille, France
[3] Hop Purpan, Serv Rhumatol, F-31059 Toulouse, France
[4] CHU Bellevue, INSERM, U1059, Serv Rhumatol, F-42055 St Etienne, France
[5] Univ Angers, Serv Rhumatol, CHU Angers, F-49033 Angers 01, France
[6] Grp Hosp Paris St Joseph, Serv Rhumatol, F-75674 Paris 14, France
关键词
Osteoporosis; Bone mineral density; Fracture; Glucocorticoids; Treatment; CORTICOSTEROID-INDUCED OSTEOPOROSIS; ORAL CORTICOSTEROIDS; RHEUMATOID-ARTHRITIS; VERTEBRAL FRACTURE; RISK; PREVENTION; EPIDEMIOLOGY; METAANALYSIS; MANAGEMENT; THRESHOLD;
D O I
10.1016/S1297-319X(11)70008-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S214 / S217
页数:4
相关论文
共 50 条
  • [1] Management of glucocorticoid-induced osteoporosis: lessons for clinical practice
    Roux, Christian
    Rajzbaum, Gerald
    Morel, Gauthier
    Legrand, Erick
    Laroche, Michel
    Hoppe, Emmanuel
    Chopin, Florence
    Borg, Severine
    Biver, Emmanuel
    Cortet, Bernard
    Thomas, Thierry
    JOINT BONE SPINE, 2011, 78 : S222 - S226
  • [2] Prevention of glucocorticoid-induced osteoporosis
    van Brussel, M. S.
    Bultink, I. E. M.
    Lems, W. F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (06) : 997 - 1005
  • [3] Glucocorticoid-induced osteoporosis: who to treat with what agent?
    Rizzoli, Rene
    Biver, Emmanuel
    NATURE REVIEWS RHEUMATOLOGY, 2015, 11 (02) : 98 - 109
  • [4] Glucocorticoid-induced osteoporosis
    den Uyl, D.
    Bultink, I. E. M.
    Lems, W. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : S93 - S98
  • [5] Glucocorticoid-induced Osteoporosis
    Whittier, Xena
    Saag, Kenneth G.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (01) : 177 - +
  • [6] Treatment options for glucocorticoid-induced osteoporosis
    Chiodini, Iacopo
    Merlotti, Daniela
    Falchetti, Alberto
    Gennari, Luigi
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (06) : 721 - 732
  • [7] Glucocorticoid-induced osteoporosis: an update
    Compston, Juliet
    ENDOCRINE, 2018, 61 (01) : 7 - 16
  • [8] Update on Glucocorticoid-Induced Osteoporosis
    Maricic, Michael
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2011, 37 (03) : 415 - +
  • [9] 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis
    Briot, Karine
    Cortet, Bernard
    Roux, Christian
    Fardet, Laurence
    Abitbol, Vered
    Bacchetta, Justine
    Buchon, Daniel
    Debiais, Francoise
    Guggenbuhl, Pascal
    Laroche, Michel
    Legrand, Erik
    Lespessailles, Eric
    Marcelli, Christian
    Weryha, Georges
    Thomas, Thierry
    JOINT BONE SPINE, 2014, 81 (06) : 493 - 501
  • [10] Glucocorticoid-Induced Osteoporosis
    Buckley, Lenore
    Humphrey, Mary B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26) : 2547 - 2556